Coagulation factor deficiency as a cause of recurrent fetal loss: A red herring!

Blood Coagulation and Fibrinolysis

Volumn 18, Issue 6, 2007, Pages 571-574

  Vora, Sonal ^a   Shetty, Shrimati ^a   Ghosh, Kanjaksha ^a  

^a KEM HOSPITAL   (India)

Author keywords

Antiphospholipid antibodies; Coagulation factor deficiency; Recurrent fetal loss

Indexed keywords

BLOOD CLOTTING FACTOR; BLOOD CLOTTING FACTOR 10; BLOOD CLOTTING FACTOR 11; BLOOD CLOTTING FACTOR 7; PHOSPHOLIPID ANTIBODY; PLASMINOGEN ACTIVATOR INHIBITOR 1; PROTEIN C; VON WILLEBRAND FACTOR;

ADULT; ARTICLE; BLOOD CLOTTING FACTOR DEFICIENCY; CLINICAL ARTICLE; FEMALE; FETUS WASTAGE; GENETIC POLYMORPHISM; HERRING; HOMOZYGOTE; HUMAN; HUMAN TISSUE; PREGNANCY OUTCOME; PRIORITY JOURNAL; THROMBOPHILIA;

ABORTION, HABITUAL; ADULT; ANNEXIN A5; ANTIBODIES, ANTICARDIOLIPIN; ANTIBODIES, ANTIPHOSPHOLIPID; COAGULATION PROTEIN DISORDERS; FEMALE; HUMANS; PLASMINOGEN ACTIVATOR INHIBITOR 1; PREGNANCY; PROTEIN C DEFICIENCY;

EID: 34447342569     PISSN: 09575235     EISSN: None     Source Type: Journal    
DOI: 10.1097/MBC.0b013e328201c8b7     Document Type: Article

References (24)

1. Wilcox AJ, Weinberg CR, O'Connor JF, Baird DD, Schlatterer JP, Canfield RE, et al. Incidence of early loss in pregnancy. N Engl J Med 1988; 319:189-194.
2. Bick RL. Recurrent miscarriage syndrome and infertility caused by blood coagulation protein or platelet defects. Hematol Oncol Clin North Am 2000; 14:1117-1131.
3. Valnicek S, Vacl J, Marazova M, Soska J, Dvorak R, Bila K. Hemotherapeutic safeguarding of induced abortion in inborn proconvertin insufficiency (hemagglutination factor VII) using exchange plasmapheresis. Zentralbl Gynakol 1972; 94:931-935.
4. Nelson DB, Ness RB, Grisso JA, Cushman M. Influence of hemostatic factors on spontaneous abortion. Am J Perinatol 2001; 4:195-201.
5. Owen CA, Henriksen RA, Mc Duffle FC, Mann KG. Prothrombin Quick: a newly identified dysprothrombinemia. Mayo Clin Proc 1978; 53:29-33.
6. Duckert F. The fibrin stabilizing factor, factor XIII. Blut 1973; 26:177-179.
7. Dossenbach-Glaninger A, van Trotsenburg M, Dossenbach C, Oberkanins C, Moritz A, Krugluger W, et al. Plasminogen activator inhibitor 1 4G/5G polymorphism and coagulation factor XIII Val34Leu polymorphism; impaired fibrinolysis and early pregnancy loss. Clin Chem 2003; 49:1081-1086.
8. Pauer HU, Burfeind P, Kostering H, Emons G, Hinney B. Factor XII deficiency is strongly associated with primary recurrent abortions. Fertil Steril 2003; 80:590-594.
9. Jones DW, Gallimore MJ, Winter M. Antibodies to factor XII: a possible predictive marker for recurrent fetal loss. Immunobiology 2003; 207:43-46.
10. Robertson L, Wu O, Langhorne P, Twaddle S, Clark P, Lowe GDO, et al. Thrombotic risk and economic assessment of thrombophilia screening (TREATS) study. Thrombophilia in pregnancy: a systematic review. Br J Haematol 2006; 132:171-196.
11. Dacie JV, Lewis SM. Practical haematology, 7th ed. Edinburgh: Churchill Livingstone; 1991.
12. Exner T, Rickard KA, Kronenberg H. A sensitive test demonstrating lupus anticoagulant and its behavioural patterns. Br J Haematol 1978; 40:143-145.
13. Thiagarajan P, Pengo V, Shapiro SS. The use of the dilute Russel Viper Venom time for the diagnosis of lupus anticoagulants. Blood 1986; 68:869-874.
14. Sambrook J, Fritsch EF, Manniatis T. Molecular cloning: a laboratory manual. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press; 1989.
15. Arruda VR, Annichino-Bizzacchi JM, Costa FF, Reitsma PH. Factor V Leiden (FVQ506) is common Brazilian population. Am J Hematol 1995; 49:242-243.
16. Poort SR, Rosendaal R, Leitsma PH, Bertina RM. A common genetic variation in the 3/translocated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis. Blood 1996; 88:3698-3703.
17. Abbate R, Sardi I, Pepe G, Marcucci R, Brunelli T, Prisco D, et al. The high prevalence of Thermolabile 5-10 methylinetetrahydrofolate reductase risk for coronary artery disease (CAD). Thromb Haemost 1998; 79:727-738.
18. Akar N, Gokdemir R, Ozel D, Akar E. EPCR gene exon III, 23 bp insertion mutation in Turkish paediatric thrombotic patients. Thromb Haemost 2002; 88:1068-1069.
19. Morange PE, Henry M, Tregouet D, Granel B, Aillaud MF, Alessi MC, Juhan-Vague I. The A-844 G polymorphism in the PAI-1 gene is associated with a higher risk of venous thrombosis in factor V Leiden carriers. Arteioscler Thromb Vasc Biol 2000; 20:1387-1391.
20. Bizzaro N, Antico A, Musso M, Platzgummer S, Camogliano L, Tozzoli R, Villalta D. A prospective study of 1038 pregnancies on the predictive value of antiannexin V antibodies for fetal loss. Ann NY Acad Sci 2005; 1050:348-356.
21. Dewerchin M, Liang Z, Moons L, Carmeliet P, Castellino FJ, Collen D, Rosen ED. Blood coagulation factor deficiency causes partial embryonic lethality and fatal neonatal bleeding in mice. Thromb Haemost 2000; 83:185-189.
22. Ghosh K, Shetty S, Mohanty D. Milder clinical presentation of haemophilia A with severe deficiency of factor VIII as measured by one stage assay. Haemophilia 2001; 7:9-12.
23. van 't Veer C, Golden NJ, Kalafais M, Simioni P, Bertina RM, Mann KG. An in vitro analysis of the combination of haemophilia A and factor V (Leiden). Blood 1997; 90:3067-3072.
24. Chan JCY, Comelissen I, Collen D, Victoria A, Castellino FJ. Combined factor VII/protein C deficiency results in intrauterine coagulopathy in mice. J Clin Invest 2000; 105:897-903.